Bioharvest Sciences [BHST] vs Kellanova [K] Detailed Stock Comparison

Bioharvest Sciences Inc.

NASDAQ
Loading...

Kellanova Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Bioharvest Sciences Inc. wins in 5 metrics, Kellanova Inc. wins in 14 metrics, with 0 ties. Kellanova Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bioharvest Sciences Inc. Kellanova Inc. Better
P/E Ratio (TTM) -7.30 22.80 Kellanova Inc.
Price-to-Book Ratio 3.90 6.91 Bioharvest Sciences Inc.
Debt-to-Equity Ratio 55.42 145.10 Bioharvest Sciences Inc.
PEG Ratio -51.53 -1.36 Kellanova Inc.
EV/EBITDA -17.68 15.33 Kellanova Inc.
Profit Margin (TTM) -32.27% 10.08% Kellanova Inc.
Operating Margin (TTM) -12.37% 15.03% Kellanova Inc.
EBITDA Margin (TTM) N/A 15.03% N/A
Return on Equity -83.17% 32.11% Kellanova Inc.
Return on Assets (TTM) -9.59% 7.64% Kellanova Inc.
Free Cash Flow (TTM) $-9.58M $1.13B Kellanova Inc.
Dividend Yield N/A 3.45% N/A
1-Year Return -38.34% 3.57% Kellanova Inc.
Price-to-Sales Ratio (TTM) 2.88 2.29 Kellanova Inc.
Enterprise Value $90.35M $35.11B Kellanova Inc.
EV/Revenue Ratio 2.62 2.77 Bioharvest Sciences Inc.
Gross Profit Margin (TTM) 57.63% 33.25% Bioharvest Sciences Inc.
Revenue per Share (TTM) $2 $37 Kellanova Inc.
Earnings per Share (Diluted) $-0.60 $3.66 Kellanova Inc.
Beta (Stock Volatility) 1.40 0.25 Kellanova Inc.
Short % of Float 0.34% 3.54% Bioharvest Sciences Inc.

Bioharvest Sciences Inc. vs Kellanova Inc. Stock Performance Analysis

Loading Price Chart...

BHST
K

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bioharvest Sciences Inc.-1.66%-9.18%-14.01%-19.09%-45.40%-31.67%
Kellanova Inc.0.00%0.35%0.14%4.85%2.24%2.20%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bioharvest Sciences Inc.-38.34%-35.67%-35.67%-35.67%-35.67%-35.67%
Kellanova Inc.3.57%24.65%43.15%25.55%73.47%99.09%

Performance & Financial Health Analysis: Bioharvest Sciences Inc. vs Kellanova Inc.

MetricBHSTK
Market Information
Market Cap i$99.29M$29.03B
Market Cap CategoryMicro capLarge cap
10 Day Avg. Volume i14,6106,612,546
90 Day Avg. Volume i23,6203,818,599
Last Close$3.56$83.44
52 Week Range$3.54 - $12.80$76.48 - $83.65
% from 52W High-72.19%-0.25%
All-Time High$12.80 (Oct 07, 2025)$83.65 (Nov 25, 2025)
% from All-Time High-72.19%-0.25%
Growth Metrics
Quarterly Revenue Growth0.25%0.01%
Quarterly Earnings Growth0.25%-0.16%
Financial Health
Profit Margin (TTM) i-0.32%0.10%
Operating Margin (TTM) i-0.12%0.15%
Return on Equity (TTM) i-0.83%0.32%
Debt to Equity (MRQ) i55.42145.10
Cash & Liquidity
Book Value per Share (MRQ)$1.12$12.08
Cash per Share (MRQ)$1.02$0.71
Operating Cash Flow (TTM) i$-7,226,000$1.26B
Levered Free Cash Flow (TTM) i$-10,782,250$504.00M
Dividends
Last 12-Month Dividend Yield iN/A3.45%
Last 12-Month Dividend iN/A$2.87

Valuation & Enterprise Metrics Analysis: Bioharvest Sciences Inc. vs Kellanova Inc.

MetricBHST (Apr 26, 2026)K (Dec 29, 2025)
Price Ratios
P/E Ratio (TTM) i-7.3022.80
Forward P/E i-51.5321.97
PEG Ratio i-51.53-1.36
Price to Sales (TTM) i2.882.29
Price to Book (MRQ) i3.906.91
Market Capitalization
Market Capitalization i$99.29M$29.03B
Enterprise Value i$90.35M$35.11B
Enterprise Value Metrics
Enterprise to Revenue i2.622.77
Enterprise to EBITDA i-17.6815.33
Risk & Other Metrics
Beta i1.400.25
Book Value per Share (MRQ) i$1.12$12.08

Financial Statements Comparison: Bioharvest Sciences Inc. vs Kellanova Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBHST (2025)K (2024)
Revenue/Sales i34.51M12.75B
Cost of Goods Sold i14.03M8.20B
COGS % of Revenue i40.7%64.4%
Gross Profit i20.48M4.55B
Gross Margin i59.3%35.6%
Research & Development i5.31MN/A
Operating Income (EBIT) i-5.58M1.87B
Operating Margin i-16.2%14.7%
EBITDA i-4.88M2.33B
EBITDA Margin i-14.1%18.3%
Pre-Tax Income i-11.06M1.65B
Pre-Tax Income % of Revenue i-32.0%13.0%
Income Tax i76,000304.00M
Income Tax % of Revenue i0.2%2.4%
Net Income (Profit) i-11.14M1.36B
Profit Margin i-32.3%10.6%

Balance Sheet & Liquidity Metrics

MetricBHST (2025)K (2024)
Cash & Equivalents i23.03M694.00M
Total Current Assets i30.50M3.75B
Total Current Assets % of Revenue i88.4%29.4%
Total Current Liabilities i7.68M4.66B
Total Current Liabilities % of Revenue i22.3%36.6%
Long-Term Debt i12.55M5.46B
Long-Term Debt % of Revenue i36.4%42.9%
Total Shareholders Equity i25.45M3.88B
Retained Earnings i-107.55M9.36B
Retained Earnings % of Revenue i-311.7%73.4%
Property, Plant & Equipment i830,000601.00M

Cash Flow Statement Comparison

MetricBHST (2025)K (2024)
Operating Cash Flow i-7.71M1.71B
Operating Cash Flow % of Revenue i-22.3%13.4%
Capital Expenditures i-2.36M-628.00M
Free Cash Flow i-9.58M1.13B
FCF Margin i-27.8%8.9%
Debt Repayment i-7.15M-682.00M
Common Stock Repurchase iN/A0

Short Interest & Institutional Ownership Analysis

MetricBHSTK
Shares Short i65,29210.48M
Short Ratio i2.414.47
Short % of Float i0.34%3.54%
Shares Outstanding i22.67M347.93M
Float Shares i17.82M343.08M
% Held by Insiders i16.60%0.51%
% Held by Institutions i8.28%87.64%
% Held by Public i75.12%11.85%

Dividend Analysis & Yield Comparison: Bioharvest Sciences Inc. vs Kellanova Inc.

MetricBHSTK
Last 12-Month Dividend iN/A$2.87
Last 12-Month Dividend Yield iN/A3.45%
3-Year Avg Annual Dividend iN/A$3.40
3-Year Avg Dividend Yield iN/A1.29%
3-Year Total Dividends iN/A$10.20
Ex-Dividend DateN/ADec 01, 2025